Veracyte (VCYT) EBITDA Margin (2012 - 2026)
Veracyte (VCYT) posted quarterly EBITDA Margin of 15.29% for Q2 2026, up 1933.0% year-over-year from 0.75% in Q2 2025, and down 6.12% on a QoQ basis from 16.28% in Q1 2026.
Veracyte (VCYT) EBITDA Margin (2012 - 2026) Analysis & Trends
Veracyte has reported EBITDA Margin for 15 years, with the latest figure at 15.29% in Q2 2026.
- EBITDA Margin for Q2 2026 came in at 15.29%, up 1933.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 18.82% (up 1594.0% YoY), and the FY2025 annual result was 11.17%, up 755.0% from the prior year.
- EBITDA Margin slipped to 15.29% in Q2 2026, from 16.28% in the prior quarter.
- Over five years, EBITDA Margin peaked at 26.45% in Q4 2025 and troughed at 36.16% in Q4 2023.
- A 5-year average of 3.49% and a median of 4.43% in 2024 frame the typical range for EBITDA Margin.
- The widest annual swing landed in 2022, when EBITDA Margin soared 10124 bps; it then plunged 2941 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 6.75% in 2022, then sank by 436 bps to 36.16% in 2023, then surged by 110 bps to 3.52% in 2024, then soared by 652 bps to 26.45% in 2025, then sank by 42 bps to 15.29% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 15.29% in Q2 2026, 16.28% in Q1 2026, and 26.45% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn | 15.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.29% |
| Mar 31, 2026 | 16.28% |
| Dec 31, 2025 | 26.45% |
| Sep 30, 2025 | 17.40% |
| Jun 30, 2025 | -4.05% |
| Mar 31, 2025 | 2.54% |
| Dec 31, 2024 | 3.52% |
| Sep 30, 2024 | 10.37% |
| Jun 30, 2024 | 4.03% |
| Mar 31, 2024 | -4.81% |
| Dec 31, 2023 | -36.16% |
| Sep 30, 2023 | -35.22% |
| Jun 30, 2023 | -8.91% |
| Mar 31, 2023 | -12.74% |
| Dec 31, 2022 | -6.75% |
| Sep 30, 2022 | -12.81% |
| Jun 30, 2022 | -14.73% |
| Mar 31, 2022 | -22.50% |
| Dec 31, 2021 | -18.32% |
| Sep 30, 2021 | -27.63% |